Conferences & Events

Found 68,816 articles

• Aimmune to Present AR101 Data at European Academy of Allergy and Clinical Immunology 2019 Congress

  5/24/2019

  Full Results from Phase 3 ARTEMIS Study Will Be Featured

• Epilepsy Foundation Awards $200,000 in Grants to Support Development of Innovative Products for Epilepsy Diagnosis & Treatment

  5/24/2019

  IBE President Dr. Martin Brodie Receives Epilepsy Lifetime Accelerator Award at AEDD

• Novocure to Participate in the Jefferies 2019 Global Healthcare Conference

  5/24/2019

  Novocure announced that Bill Doyle, Novocure’s Executive Chairman, will participate in the Jefferies 2019 Global Healthcare Conference on June 4, 2019, in New York City.

• Alpine Immune Sciences to Present at Upcoming Investor Conferences

  5/24/2019

  Alpine Immune Sciences, Inc. announced the company will participate in three upcoming investor conferences in June.

• New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting

  5/24/2019

  Ipsen announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib, liposomal irinotecan, and lanreotide autogel will be presented at the 2019 American Society of Clinical Oncology Annual Meeting.

• CENTOGENE Welcomes Germany’s Chancellor Dr. Angela Merkel

  5/23/2019

  CENTOGENE welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig, Minister-President of Mecklenburg-Vorpommern.

• MorphoSys AG Reports Outcome of Annual General Meeting 2019

  5/23/2019

  All Resolutions Proposed by the Company's Management Approved

• IQVIA to Participate in William Blair Growth Stock Conference on June 5, 2019

  5/23/2019

  IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the William Blair 39th Annual Growth Stock Conference in Chicago, IL on Wednesday, June 5, 2019 at 10:40 a.m. CT / 11:40 a.m. ET.

• Comedy vs Cancer Surpasses $1 Million For Cancer Research at Memorial Sloan Kettering Cancer Center

  5/23/2019

  Comedy vs Cancer, a night of humor and hope to outwit blood cancers, raised more than $1 million for research at Memorial Sloan Kettering Cancer Center. There were 1,000 people in the audience for the sold-out show in New York City on Tuesday, May 14 at Jazz at Lincoln Center's Frederick P. Rose Hall.

• Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4

  5/23/2019

  Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Ilan Daskal, Executive Vice President and CFO, will participate in Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, at 10 AM (Eastern Time), in New York, NY.

• Leading Medical Companies And Investors Gather In San Francisco For Oppenheimer's MedTech Day

  5/23/2019

  Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – will host its first MedTech Day on May 29, 2019 at the Hilton Union Square in San Francisco, CA

• NeurologyLive® Launches ‘Understanding Hereditary ATTR (hATTR) Amyloidosis and the Recent Advances in Management’

  5/23/2019

  NeurologyLive®, a digital and print multimedia platform dedicated to providing health care professionals treating neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, presents its most recent “Peer Exchange” panel discussion, “Understanding Hereditary ATTR (hATTR) Amyloidosis and the Recent Advances in Management.

• Therapix Biosciences Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Non-Compliance

  5/23/2019

  Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today that it received a written notification from the Listing Qualifications Department of The Nasdaq Capital Market

• Millendo Therapeutics to Present at Jefferies 2019 Healthcare Conference

  5/23/2019

  Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, announced today that Julia C. Owens, Ph.D., President and Chief Executive Officer, will present at the Jefferies 2019 Healthcare Conference in New York City on Thursday, June 6, 2019 at 11:00 a.m. ET.

• ResMed Announces Participation in the 39th Annual William Blair Growth Stock Conference

  5/23/2019

  ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 39th Annual William Blair Growth Stock Conference on Thursday, June 6, 2019, beginning at approximately 8:40 a.m. (Central Time) at the Loews Chicago Hotel in Chicago.

• International Biophysics announces renewed commitment to helping grow awareness of Cystic Fibrosis and Mobile HFCWO Airway Clearance

  5/23/2019

  International Biophysics Corporation, manufacturer of the AffloVest is committed to raising awareness of Cystic Fibrosis and the importance of airway clearance therapy in the management of the disease

• VITAS® Healthcare's Marketing Team Earns 16 Aster Awards for Healthcare Advertising

  5/23/2019

  VITAS® Healthcare, the nation's leading provider of end-of-life care, has won 16 awards for multimedia marketing from the Aster Awards, an elite competition recognizing outstanding excellence in healthcare advertising.

• Volunteers of America Launches Moral Injury Initiatives

  5/23/2019

   Volunteers of America has launched a significant moral injury initiative by establishing the Shay Moral Injury Center.

• Veracyte Announces New Data Demonstrating Afirma Xpression Atlas’s Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting

  5/23/2019

  American Society of Clinical Oncology (ASCO) Annual Meeting being held May 31-June 4, 2019 in Chicago.

• Essity's Investor Day 2019

  5/23/2019

  Essity, the global hygiene and health company, is holding its Investor Day in Stockholm, Sweden.